Source https://www.researchgate.net/publication/332989478_Biodegradable_temporising_matrix_for_necrotising_soft_tissue_infections_a_case_report

is in Australia; I assume that the patient went home after being in Bali before presenting to the hospital:

A 42-year-old man with septic shock secondary to NCTS of the right leg and arm was transferred to a third-level trauma hospital for further management and adjuvant hyperbaric therapy. The patient was a healthy man, avid surfer, who had suffered abrasions to his right leg and arm from corals while surfing in Bali four days before his presentation. After four extensive debridements, the total loss of soft tissue in his anterior abdomen, right thigh, circumferential right leg, back of right foot, and right arm (Figure 1) was 32% of his body surface area.

On day 17 after admission, the patient’s wounds appeared clean and the cultures were negative. Reconstruction began with cadaveric allografts as a temporary dressing, to improve and prepare the granulation tissue. However, these allografts became infected with Pseudomonas aeruginosa. Further debridement of the infected devitalized tissue led to the exposure of tendons in the anterior compartment of the right leg, becoming parched and lacking paratenon — hence the fact that this part of the wound was no longer graftable. Free tissue transfer was ruled out due to infection, the large size of the soft tissue defect, and the presence of suboptimal vessel vessels in the area of infection.

At the time, Novosorb BTM was being tested in our facility for the management of extensive burns. It was decided to use this dermal substitute to create a graftable bed in the right leg and back of the foot, specifically targeting exposed tendons. Permission from the Australian Therapeutic Property Administration has been obtained for its use in this case.

On day 37 after admission, the right leg and back of the foot were surgically prepared and implanted with Novosorb BTM. Current protocols require implantation of BTMs on a clean, uninfected wound prepared with betadine. The BTM is secured with quilting clips and dressed with Acticoat™ (Smith & Nephew, London, UK).

As recommended, the patient underwent regular dressing changes as the implanted BTM integrated over the next 21 days, allowing for monitoring of hematoma formation and infection. During this period, the BTM became progressively more hyperemic and vascularized (Figure 2). Twenty-four days after implantation, the surface sealing layer of the BTM was “delaminated,” revealing a vascularized matrix. The tendons in the anterior compartment of the right leg were no longer exposed. The wounds were then reconstructed using a 2:1 mesh SSG [full-thickness skin graft].

Eighty-three days after admission, the patient was transferred to a rehabilitation hospital. The majority of his grafts had healed, with the exception of small areas of hypergranulation (Figure 3), which were resolved with dressings. Twenty months after the last SSG, he reached 10° dorsiflexion and 30° plantar flexion in his right ankle. He currently walks independently without aids, works full-time in sales and has returned to surfing. (!!!)